>
Switch to:

Calliditas Therapeutics AB PS Ratio

: 9,466.67 (As of Today)
View and export this data going back to 2020. Start your Free Trial

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Calliditas Therapeutics AB's share price is $28.40. Calliditas Therapeutics AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $0.00. Hence, Calliditas Therapeutics AB's PS Ratio for today is 9,466.67.

NAS:CALT' s PS Ratio Range Over the Past 10 Years
Min: 12.51   Med: 22.3   Max: 10328.57
Current: 8580.31

12.51
10328.57

During the past 6 years, Calliditas Therapeutics AB's highest PS Ratio was 10328.57. The lowest was 12.51. And the median was 22.30.

NAS:CALT's PS Ratio is ranked lower than
99.99% of the 1036 Companies
in the Drug Manufacturers industry.

( Industry Median: 3.20 vs. NAS:CALT: 8580.31 )

Calliditas Therapeutics AB's Revenue per Sharefor the three months ended in Dec. 2020 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $0.00.

During the past 12 months, the average Revenue per Share Growth Rate of Calliditas Therapeutics AB was -99.60% per year.

Back to Basics: PS Ratio


Calliditas Therapeutics AB PS Ratio Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
PS Ratio Premium Member Only 0.00 0.00 0.00 14.83 9,971.43

Calliditas Therapeutics AB Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.83 16.56 93.30 88.01 9,971.43

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Calliditas Therapeutics AB PS Ratio Distribution

* The bar in red indicates where Calliditas Therapeutics AB's PS Ratio falls into.



Calliditas Therapeutics AB PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Calliditas Therapeutics AB's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=28.40/0.003
=9,466.67

Calliditas Therapeutics AB's Share Price of today is $28.40.
Calliditas Therapeutics AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was 0.001 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) + 0.002 (Dec. 2020 ) = $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Calliditas Therapeutics AB  (NAS:CALT) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Calliditas Therapeutics AB PS Ratio Related Terms


Calliditas Therapeutics AB PS Ratio Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)